Lee JY, Kim S-A, Yang D-H, Eum H-S, Lee M-W, Lee HJ, Kwak J-Y, Park YH, Do YR, Lee J-O. Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphoma. Haematologica; https://doi.org/10.3324/haematol.2026.300790 [Early view].